CID 156565109

Birelentinib

Structural Information

Molecular Formula
C23H21F2N5O3
SMILES
C1C[C@H](OC[C@@H]1C2=NC(=C3N2N=CN=C3N)C4=CC=C(C=C4)OC5=C(C(=CC=C5)F)F)CO
InChI
InChI=1S/C23H21F2N5O3/c24-17-2-1-3-18(19(17)25)33-15-7-4-13(5-8-15)20-21-22(26)27-12-28-30(21)23(29-20)14-6-9-16(10-31)32-11-14/h1-5,7-8,12,14,16,31H,6,9-11H2,(H2,26,27,28)/t14-,16+/m1/s1
InChIKey
NQJKXHPWHYRGST-ZBFHGGJFSA-N
Compound name
[(2S,5S)-5-[4-amino-5-[4-(2,3-difluorophenoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl]oxan-2-yl]methanol
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

1
Patents

453.16125 Da
Monoisotopic Mass

2.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 454.16853 209.0
[M+Na]+ 476.15047 218.1
[M-H]- 452.15397 214.7
[M+NH4]+ 471.19507 212.1
[M+K]+ 492.12441 210.6
[M+H-H2O]+ 436.15851 194.4
[M+HCOO]- 498.15945 221.0
[M+CH3COO]- 512.17510 215.8
[M+Na-2H]- 474.13592 208.0
[M]+ 453.16070 206.9
[M]- 453.16180 206.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe